During the 'Lightning Round' segment of Mad Money callers get to ask Jim Cramer what he thinks about stocks they are interested in. One caller on Wednesday night asked about Lam Research Corp. (LRCX) : "This stock is a buy on a pullback," said Cramer. Let's check the charts.
More from Investing
No news can explain the action -- whether the bears believe it or not.
The last few post-earnings beat downs were greeted with optimism once traders got over the initial disappointment.
Forte's sole clinic candidate is FB-401 for the treatment of atopic dermatitis, which is the scientific name for eczema.